These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16179095)

  • 1. Chemoprevention strategies for patients with lung cancer in the context of screening.
    Saba NF; Khuri FR
    Clin Lung Cancer; 2005 Sep; 7(2):92-9. PubMed ID: 16179095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention in lung cancer.
    Reddy SC; Khuri FR
    J Med Assoc Ga; 2003; 92(1):27-33. PubMed ID: 12743903
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing targeted therapies for lung cancer.
    Gandara DR
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoprevention of lung cancer: soon daily practice?
    van Zandwijk N; Pastorino U
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):91-8. PubMed ID: 12597353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of lung cancer: current status and future prospects.
    van Zandwijk N; Hirsch FR
    Lung Cancer; 2003 Dec; 42 Suppl 1():S71-9. PubMed ID: 14611918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer chemoprevention: an integrated approach.
    Lippman SM; Spitz MR
    J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
    Crawford J
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination epidermal growth factor receptor inhibition and radical radiotherapy for NSCLC.
    Rogers SJ; Harrington KJ; Eccles SA; Nutting CM
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):569-83. PubMed ID: 15270661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of lung cancer.
    Benner SE; Lippman SM; Hong WK
    Chest; 1995 Jun; 107(6 Suppl):316S-321S. PubMed ID: 7781413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The finding of premalignant lesions is not associated with smoking cessation in chemoprevention study volunteers.
    Schook RM; Postmus BB; van den Berg RM; Sutedja TG; Man de FS; Smit EF; Postmus PE
    J Thorac Oncol; 2010 Aug; 5(8):1240-5. PubMed ID: 20581710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of lung cancer.
    Vignot S; Spano JP; Lantuejoul S; André F; Le Chevalier T; Soria JC
    Recent Results Cancer Res; 2005; 166():145-65. PubMed ID: 15648189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel targeted therapies for non-small cell lung cancer.
    Smith PW; Denlinger CE; Jones DR
    Thorac Surg Clin; 2006 Nov; 16(4):353-66. PubMed ID: 17240823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecularly targeted approaches to the chemoprevention of lung cancer.
    Khuri FR; Cohen V
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4249s-4253s. PubMed ID: 15217968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.
    Mao JT; Cui X; Reckamp K; Liu M; Krysan K; Dalwadi H; Sharma S; Hazra S; Strieter R; Gardner B; Dubinett SM
    Clin Lung Cancer; 2005 Jul; 7(1):30-9. PubMed ID: 16098242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists.
    Silvestri GA; Rivera MP
    Chest; 2005 Dec; 128(6):3975-84. PubMed ID: 16354869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention strategies for non-small cell lung cancer.
    van Zandwijk N; Hirsch FR
    Curr Opin Oncol; 2002 Mar; 14(2):185-90. PubMed ID: 11880709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.
    Gridelli C; Massarelli E; Maione P; Rossi A; Herbst RS; Onn A; Ciardiello F
    Cancer; 2004 Oct; 101(8):1733-44. PubMed ID: 15386339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
    Kris MG; Natale RB; Herbst RS; Lynch TJ; Prager D; Belani CP; Schiller JH; Kelly K; Spiridonidis H; Sandler A; Albain KS; Cella D; Wolf MK; Averbuch SD; Ochs JJ; Kay AC
    JAMA; 2003 Oct; 290(16):2149-58. PubMed ID: 14570950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of lung cancer.
    Kim ES; Khuri FR
    Curr Oncol Rep; 2002 Jul; 4(4):341-6. PubMed ID: 12044244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase as a target in lung cancer.
    Brown JR; DuBois RN
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.